EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022 -





Published: August 2013 | Pages: 122 | Format: PDF

Summary 

Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the likelihood of developing type 2 diabetes and cardiovascular diseases. Obesity is an escalating public health problem with an increasing worldwide prevalence and has become a well-known threat to public health. As obesity is a complex condition associated with a wide range of lifestyle, genetic, social, cultural, and environmental factors, its prevalence may vary across countries, depending on the variations in these contributing factors. 

GlobalData's epidemiological analysis forecasts that prevalent cases of overweight in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada) will increase from 250.05 million in 2012 to 271.86 million cases in 2022 at an annual growth rate (AGR) of 0.86%. Approximately 57% of the 250.05 million prevalent cases of overweight adults in the 9MM in 2012 were in men. GlobalData epidemiologists forecast that there were 167.39 million prevalent cases of obesity in the 9MM in 2012, which will increase to 213.34 million cases in 2022, increasing at an AGR of 2.75%. Approximately 52% of the 167.39 million prevalent cases of obese adults in the 9MM in 2012 were in women. 

According to GlobalData's forecast, the prevalent cases of both overweight and obesity will increase dramatically over the next decade, with the number of obese adults increasing by an alarming 27.50%. Overweight and obesity have reached pandemic proportions; however, GlobalData epidemiologists believe that with the alarming increase in the prevalence of both overweight and obesity, the morbidity and mortality associated with the disease will continue to increase dramatically as well. 

Scope 

 

  • The Overweight and Obesity EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of overweight and obesity in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada). It includes a 10-year epidemiology forecast of the prevalent cases of overweight, obesity, obesity class I, obesity class II, and obesity class III segmented by sex and age. In addition, the report includes a 10-year forecast of the prevalent cases of obesity-associated comorbidities, including diagnosed diabetes, diagnosed hypertension, and dyslipidemia, among adults with overweight/obesity in some of these markets. 
  • The overweight and obesity epidemiology report is written and developed by Masters- and PhD-level epidemiologists. 
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM. 

 

Reasons to buy 

 

  • Develop business strategies by understanding the trends shaping and driving the global overweight and obesity market. 
  • Quantify patient populations in the global overweight and obesity market to improve product design, pricing, and launch plans. 
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for overweight and obesity therapeutics in each of the markets covered. 
  • Identify the number of obesity class I, obesity class II, and obesity class III prevalent cases. 

 

 

1 Table of Contents 

1 Table of Contents 4 

1.1 List of Tables 7 

1.2 List of Figures 8 

2 Introduction 10 

2.1 Catalyst 10 

2.2 Related Reports 11 

3 Epidemiology 12 

3.1 Disease Overview 12 

3.2 Risk Factors and Comorbidities 13 

3.2.1 Family history is a strong predictor of obesity 13 

3.2.2 Physical inactivity is an independent predictor of obesity 14 

3.2.3 Excessive caloric intake doubles the risk for obesity 15 

3.2.4 Hypertension is as high as 42% in obese adults 16 

3.2.5 Dyslipidemia and type 2 diabetes are common comorbidities in obese patients 17 

3.3 Global Trends 19 

3.3.1 US 20 

3.3.2 5EU 22 

3.3.3 Japan 28 

3.3.4 Brazil 29 

3.3.5 Canada 31 

3.4 Forecast Methodology 32 

3.4.1 Sources Used 39 

3.4.2 Forecast Assumptions and Methods: Prevalent Cases of Overweight, Obesity, Obesity by Class, and Comorbidities 46 

3.4.3 Sources Not Used 63 

3.5 Epidemiology Forecast of Overweight (2012–2022) 63 

3.5.1 Prevalent Cases of Overweight 63 

3.5.2 Age-Specific Prevalent Cases of Overweight 65 

3.5.3 Sex-Specific Prevalent Cases of Overweight 67 

3.5.4 Age-Standardized Prevalence of Overweight 70 

3.6 Epidemiology Forecast of Obesity (2012–2022) 71 

3.6.1 Prevalent Cases of Obesity 71 

3.6.2 Age-Specific Prevalent Cases of Obesity 73 

3.6.3 Sex-Specific Prevalent Cases of Obesity 75 

3.6.4 Age-Standardized Prevalence of Obesity 76 

3.7 Epidemiology Forecast of Obesity Class I (2012–2022) 77 

3.7.1 Prevalent Cases of Obesity Class I 77 

3.7.2 Age-Specific Prevalent Cases of Obesity Class I 79 

3.7.3 Sex-Specific Prevalent Cases of Obesity Class I 81 

3.7.4 Age-Standardized Prevalence of Obesity Class I 83 

3.8 Epidemiology Forecast of Obesity Class II (2012–2022) 85 

3.8.1 Prevalent Cases of Obesity Class II 85 

3.8.2 Age-Specific Prevalent Cases of Obesity Class II 87 

3.8.3 Sex-Specific Prevalent Cases of Obesity Class II 89 

3.8.4 Age-Standardized Prevalence of Obesity Class II 91 

3.9 Epidemiology Forecast of Obesity Class III (2012–2022) 93 

3.9.1 Prevalent Cases of Obesity Class III 93 

3.9.2 Age-Specific Prevalent Cases of Obesity Class III 95 

3.9.3 Sex-Specific Prevalent Cases of Obesity Class III 97 

3.9.4 Age-Standardized Prevalence of Obesity Class III 99 

3.10 Epidemiology Forecast of Comorbidities among Adults with Overweight/Obesity (2012 and 2022) 101 

3.10.1 Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity 101 

3.10.2 Prevalent Cases of Diagnosed Hypertension in Adults with Overweight/Obesity 104 

3.10.3 Prevalent Cases of Dyslipidemia among Adults with Overweight/Obesity 106 

3.11 Discussion 109 

3.11.1 Conclusions on Epidemiological Trends 109 

3.11.2 Limitations of the Analysis 110 

3.11.3 Strengths of the Analysis 111 

4 Appendix 112 

4.1 Bibliography 112 

4.2 About the Authors 118 

4.2.1 Epidemiologists 118 

4.2.2 Reviewers 118 

4.2.3 Global Director of Epidemiology and Health Policy 119 

4.2.4 Global Head of Healthcare 120 

4.3 About GlobalData 121 

4.4 About EpiCast 121 

4.5 Disclaimer 121 

 

1.1 List of Tables 

Table 1: The WHO Classification System of Adult Overweight and Obesity According to BMI 12 

Table 2: Risk Factors and Comorbidities of Obesity 13 

Table 3: 9MM, Age-Adjusted and Crude Prevalence (%) of Obesity, by Sex, Ages ?20 Years, 2008 20 

Table 4: JASSO and WHO Classifications of Obesity 28 

Table 5: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Overweight 33 

Table 6: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity 34 

Table 7: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity Class I, Class II, and Class III 36 

Table 8: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Comorbidities in Overweight/Obese 38 

Table 9: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 64 

Table 10: 9MM, Prevalent Cases of Overweight, By Age, Both Sexes, N (Millions), Row (%), 2012 66 

Table 11: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 68 

Table 12: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 72 

Table 13: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), Row (%), 2012 74 

Table 14: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), Row (%), 2012 75 

Table 15: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 78 

Table 16: 9MM, Prevalent Cases of Obesity Class I, by Age, Both Sexes, N (Millions), Row (%), 2012 80 

Table 17: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 82 

Table 18: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 86 

Table 19: 9MM, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), Row (%), 2012 88 

Table 20: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 90 

Table 21: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 94 

Table 22: 9MM, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), Row (%), 2012 96 

Table 23: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 98 

Table 24: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 102 

Table 25: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 105 

Table 26: 4MM, Prevalent Cases of Dyslipidemia* among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 107 

 

1.2 List of Figures 

Figure 1: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Men, 1960–2010 21 

Figure 2: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Women, 1960–2010 21 

Figure 3: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Men, 1997–2006 23 

Figure 4: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Women, 1997–2006 23 

Figure 5: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25 

Figure 6: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25 

Figure 7: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Men, 1993–2011 27 

Figure 8: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Women, 1993–2011 27 

Figure 9: Japan, Obesity Prevalence (%), Ages ?20 Years, By Sex, 1976–2006 29 

Figure 10: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Men, 1975–2003 30 

Figure 11: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Women, 1975–2003 30 

Figure 12: Canada, Obesity Prevalence (%), Ages ?18 Years, Both Sexes, 1978–2008 32 

Figure 13: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 65 

Figure 14: 9MM, Prevalent Cases of Overweight, by Age, Both Sexes, N (Millions), 2012 67 

Figure 15: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, by Sex, N (Millions), 2012 69 

Figure 16: 9MM, Overweight Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 71 

Figure 17: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 73 

Figure 18: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), 2012 74 

Figure 19: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), 2012 76 

Figure 20: 9MM, Obesity Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 77 

Figure 21: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 79 

Figure 22: 9MM*, Prevalent Cases of Obesity Class I, By Age, Both Sexes, N (Millions), 2012 81 

Figure 23: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, by Sex, N (Millions), 2012 83 

Figure 24: 9MM*, Obesity Class I Age-Standardized Prevalence (%), Ages ?18 Years, by Sex, 2012 84 

Figure 25: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 87 

Figure 26: 9MM*, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), 2012 89 

Figure 27: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, by Sex, N (Millions), 2012 91 

Figure 28: 9MM*, Age-Standardized Prevalence (%) of Obesity Class II, Ages ?18 Years, By Sex, 2012 92 

Figure 29: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 95 

Figure 30: 9MM*, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), 2012 97 

Figure 31: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), 2012 99 

Figure 32: 9MM*, Obesity Class III Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 100 

Figure 33: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 103 

Figure 34: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 106 

Figure 35: 4MM*, Prevalent Cases of Dyslipidemia** among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 108